A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

NCT02426034 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2004

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: ApatinibTablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.